The Relation between Total Volume of Physical Activity and Metabolic Syndrome - Prevalence at Community Health Center in Seoul, Korea -

Cha, Kwang-Suk; Hong, Sung-in; Lee, Yong-Soo

doi:10.21097/ksw.2016.02.11.1.243

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Categorical variables were analyzed using the chi-square test. Analysis of variance (ANCOVA) adjusted for MET value variations was used to determine whether the observed difference in blood TG concentration between the two groups was independent of MET value [22,23]. Also the outcome variables for repeated measurement of the intake groups were applied with a linear mixed model between the intake groups.…”

Section: Discussionmentioning

confidence: 99%

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Assessing the Effects of Angelica Gigas Nakai Extract on Blood Triglycerides

Kim

Cha

et al. 2020

Nutrients

View full text Add to dashboard Cite

Angelica gigas Nakai, Korean dang-gui, has long been widely used in traditional treatment methods. There have been a number of studies of the health effects of A. gigas and related compounds, but studies addressing effects on blood triglycerides (TG) are lacking. To investigate the effects of A. gigas Nakai extract (AGNE) on TG in Korean subjects, we carried out a 12-week, randomized, double-blind, placebo-controlled clinical trial. Subjects who met the inclusion criterion (130 mg/dL ≤ fasting blood TG ≤ 200 mg/dL) were recruited for this study. One hundred subjects were assigned to the AGNE group (n = 50) or the placebo group (n = 50), who were given 1 g/day of AGNE (as a gigas Nakai extract 200 mg/d) in capsules and the control group for 12 weeks. Outcomes were efficacy TG, lipid profiles, atherogenic index, and safety parameters were assessed initially for a baseline measurement and after 12 weeks. After 12 weeks of supplementation, TG and very low-density lipoprotein cholesterol (VLDL-C) concentration and TG/HDL-C ratio in the AGNE group were significantly reduced compared to the placebo group (p < 05). No significant changes in any safety parameter were observed. These results suggest that the ingestion of AGNE may improve TG and be useful to manage or prevent hypertriglyceridemia.

show abstract

Section: Discussionmentioning

confidence: 99%